CA3065979C - Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux - Google Patents

Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux Download PDF

Info

Publication number
CA3065979C
CA3065979C CA3065979A CA3065979A CA3065979C CA 3065979 C CA3065979 C CA 3065979C CA 3065979 A CA3065979 A CA 3065979A CA 3065979 A CA3065979 A CA 3065979A CA 3065979 C CA3065979 C CA 3065979C
Authority
CA
Canada
Prior art keywords
acid
subject
level
colorectal
metabolite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3065979A
Other languages
English (en)
Other versions
CA3065979A1 (fr
Inventor
Lu DENG
David Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolomic Technologies Inc
Original Assignee
Metabolomic Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolomic Technologies Inc filed Critical Metabolomic Technologies Inc
Priority to CA3065979A priority Critical patent/CA3065979C/fr
Publication of CA3065979A1 publication Critical patent/CA3065979A1/fr
Application granted granted Critical
Publication of CA3065979C publication Critical patent/CA3065979C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ABRÉGÉ : La présente invention concerne des méthodes et des compositions pour détecter le cancer colorectal et les polypes colorectaux par mesure des métabolites dans les fluides corporels, comme lurine, y compris la diacétylspermine et la kynurénine. CA 3065979 2019-12-23
CA3065979A 2019-12-23 2019-12-23 Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux Active CA3065979C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3065979A CA3065979C (fr) 2019-12-23 2019-12-23 Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3065979A CA3065979C (fr) 2019-12-23 2019-12-23 Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux

Publications (2)

Publication Number Publication Date
CA3065979A1 CA3065979A1 (fr) 2021-06-23
CA3065979C true CA3065979C (fr) 2023-03-14

Family

ID=76545363

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3065979A Active CA3065979C (fr) 2019-12-23 2019-12-23 Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux

Country Status (1)

Country Link
CA (1) CA3065979C (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4202413B1 (fr) * 2021-12-21 2024-01-31 Bruker Optics GmbH & Co. KG Procédé mise en oeuvre par ordinateur pour prédire des propriétés d'échantillons sur la base de mesures spectrales et système informatique pour cela
CN115097132A (zh) * 2022-04-28 2022-09-23 西北工业大学 L-肉碱、乙酰L-肉碱、β-羟基丁酸单独或联合在结直肠癌早期诊断中的应用
CN117783317A (zh) * 2023-12-01 2024-03-29 苏州大学 一种基于液相色谱质谱联用的肠道菌群多胺代谢活性检测系统

Also Published As

Publication number Publication date
CA3065979A1 (fr) 2021-06-23

Similar Documents

Publication Publication Date Title
US20240084394A1 (en) Urinary metabolomic biomarkers for detecting colorectal cancer and polyps
Dinges et al. Cancer metabolomic markers in urine: evidence, techniques and recommendations
Zhang et al. Identification of potential biomarkers for ovarian cancer by urinary metabolomic profiling
Schreuders et al. Advances in fecal tests for colorectal cancer screening
Deng et al. Urinary metabolomics to identify a unique biomarker panel for detecting colorectal cancer: a multicenter study
Xie et al. Lowered circulating aspartate is a metabolic feature of human breast cancer
Pasikanti et al. Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry
Zou et al. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis
Buas et al. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors
Hsu et al. Integrated analyses utilizing metabolomics and transcriptomics reveal perturbation of the polyamine pathway in oral cavity squamous cell carcinoma
Chan et al. Metabonomic profiling of bladder cancer
US20180180619A1 (en) Means and Methods for Diagnosing Pancreatic Cancer in a Subject Based on a Biomarker Panel
Gajbhiye et al. Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics
CN112804936A (zh) 用于预测，诊断和预后包括癌症在内的各种疾病的代谢组学签名
Wu et al. Identification of potential metabolite markers for colon cancer and rectal cancer using serum metabolomics
CN107076748A (zh) 评估乳腺癌的生物标志物
WO2022073502A1 (fr) Utilisation d'un biomarqueur dans la préparation d'un réactif de détection du cancer du poumon et produit associé
CA3065979C (fr) Biomarqueurs metabolomiques urinaires pour detecter le cancer et les polypes colorectaux
Amon et al. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer
CN120188046A (zh) 鉴定胰腺癌的方法
WO2018112428A1 (fr) Méthodes pour la détection et le traitement d'un adénocarcinome canalaire pancréatique
WO2018184112A1 (fr) Procédés de test d'urine basé sur une spectrométrie de masse à haut débit pour des affections colorectales
WO2013177222A1 (fr) Biomarqueurs métaboliques pour la détection du cancer du foie
Patel et al. Unique and novel urinary metabolomic features in malignant versus benign adrenal neoplasms
Deng et al. Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians

Legal Events

Date Code Title Description
W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250916

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U107 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REFUND REQUEST RECEIVED

Effective date: 20251216

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251230

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260108

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260204